Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Kidney ultrasound findings according to kidney function in sickle cell anemia.

Patel R, Kang S, Valeshabad AK, Shah BN, Han J, Gowhari M, Molokie RE, Xie K, Lash JP, Gordeuk VR, Saraf SL.

Am J Hematol. 2019 Nov;94(11):E288-E291. doi: 10.1002/ajh.25602. Epub 2019 Aug 18. No abstract available.

PMID:
31379007
2.

Laparoscopic Sleeve Gastrectomy in Sickle Cell Disease: a Case Series.

Han J, Gowhari M, Gordeuk VR, Saraf SL.

Obes Surg. 2019 Jun 10. doi: 10.1007/s11695-019-03983-5. [Epub ahead of print]

PMID:
31183783
3.

The morbidity and mortality of end stage renal disease in sickle cell disease.

Viner M, Zhou J, Allison D, Han J, Molokie RE, Jain S, Gowhari M, Gordeuk VR, Calip G, Saraf SL.

Am J Hematol. 2019 May;94(5):E138-E141. doi: 10.1002/ajh.25439. Epub 2019 Mar 1. No abstract available.

PMID:
30773675
4.

Integration of neuropsychology services in a sickle cell clinic and subsequent healthcare use for pain crises.

Janecek JK, Dorociak KE, Piper LE, Kelleher T, Pliskin NH, Gowhari M, Molokie RE.

Clin Neuropsychol. 2019 Oct;33(7):1195-1211. doi: 10.1080/13854046.2018.1535664. Epub 2018 Nov 24.

PMID:
30472925
5.

High inpatient dose of opioid at discharge compared to home dose predicts readmission risk in sickle cell disease.

Han J, Saraf SL, Gowhari M, Jain S, Molokie RE, Gordeuk VR.

Am J Hematol. 2019 Jan;94(1):E5-E7. doi: 10.1002/ajh.25311. Epub 2018 Oct 31. No abstract available.

PMID:
30299555
6.

HMOX1 and acute kidney injury in sickle cell anemia.

Saraf SL, Viner M, Rischall A, Raslan R, Shah BN, Zhang X, Han J, Gowhari M, Jain S, Molokie RE, Machado RF, Lash JP, Gordeuk VR.

Blood. 2018 Oct 11;132(15):1621-1625. doi: 10.1182/blood-2018-05-853929. Epub 2018 Aug 23. No abstract available.

7.

Risk factors for vitamin D deficiency in sickle cell disease.

Han J, Zhang X, Saraf SL, Gowhari M, Molokie RE, Hassan J, Jain S, Shah BN, Abbasi T, Machado RF, Gordeuk VR.

Br J Haematol. 2018 Jun;181(6):828-835. doi: 10.1111/bjh.15270. Epub 2018 May 16.

8.

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease.

Saraf SL, Oh AL, Patel PR, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Jain S, Peace D, Quigley JG, Khan I, Molokie RE, Mahmud N, Gordeuk VR, Rondelli D.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1759-1765. doi: 10.1016/j.bbmt.2018.03.031. Epub 2018 Apr 12.

9.

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG.

Blood Adv. 2017 Aug 28;1(20):1645-1649. doi: 10.1182/bloodadvances.2017009613. eCollection 2017 Sep 12. Erratum in: Blood Adv. 2017 Oct 19;1(23 ):2058.

10.

Program expansion of a day hospital dedicated to manage sickle cell pain.

Han J, Saraf SL, Kavoliunaite L, Jain S, Hassan J, Hsu LL, Molokie RE, Gordeuk VR, Gowhari M.

Am J Hematol. 2018 Jan;93(1):E20-E21. doi: 10.1002/ajh.24938. Epub 2017 Oct 31. No abstract available.

11.

Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Molokie R, Lavelle D, Gowhari M, Pacini M, Krauz L, Hassan J, Ibanez V, Ruiz MA, Ng KP, Woost P, Radivoyevitch T, Pacelli D, Fada S, Rump M, Hsieh M, Tisdale JF, Jacobberger J, Phelps M, Engel JD, Saraf S, Hsu LL, Gordeuk V, DeSimone J, Saunthararajah Y.

PLoS Med. 2017 Sep 7;14(9):e1002382. doi: 10.1371/journal.pmed.1002382. eCollection 2017 Sep.

12.

Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.

Molokie RE, Montminy C, Dionisio C, Farooqui MA, Gowhari M, Yao Y, Suarez ML, Ezenwa MO, Schlaeger JM, Wang ZJ, Wilkie DJ.

Am J Emerg Med. 2018 Jan;36(1):88-92. doi: 10.1016/j.ajem.2017.07.037. Epub 2017 Jul 13.

PMID:
28802541
13.

Erythropoiesis-stimulating agents in sickle cell anaemia.

Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL.

Br J Haematol. 2018 Aug;182(4):602-605. doi: 10.1111/bjh.14846. Epub 2017 Jul 27. No abstract available.

14.

Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways.

Han J, Zhang X, Oderinde J, Saraf SL, Gowhari M, Hassan J, Jain S, Gordeuk VR, Molokie RE.

Haematologica. 2017 Aug;102(8):e282-e284. doi: 10.3324/haematol.2017.169128. Epub 2017 May 4. No abstract available.

15.

Patterns of opioid use in sickle cell disease.

Han J, Saraf SL, Zhang X, Gowhari M, Molokie RE, Hassan J, Alhandalous C, Jain S, Younge J, Abbasi T, Machado RF, Gordeuk VR.

Am J Hematol. 2016 Nov;91(11):1102-1106. doi: 10.1002/ajh.24498. Epub 2016 Aug 8.

16.

APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia.

Saraf SL, Shah BN, Zhang X, Han J, Tayo BO, Abbasi T, Ostrower A, Guzman E, Molokie RE, Gowhari M, Hassan J, Jain S, Cooper RS, Machado RF, Lash JP, Gordeuk VR.

Haematologica. 2017 Jan;102(1):e1-e6. doi: 10.3324/haematol.2016.154153. Epub 2016 Sep 22. No abstract available.

17.

Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Han J, Bhat S, Gowhari M, Gordeuk VR, Saraf SL.

Pharmacotherapy. 2016 Nov;36(11):1166-1172. doi: 10.1002/phar.1834. Epub 2016 Oct 3.

18.

Safety of chronic transdermal fentanyl use in patients receiving hemodialysis.

Han J, Saraf SL, Gordeuk VR, Gowhari M.

Am J Health Syst Pharm. 2016 Jul 1;73(13):947-8. doi: 10.2146/ajhp150748. No abstract available.

19.

Utility of the revised cardiac risk index for predicting postsurgical morbidity in Hb SC and Hb Sβ+-thalassemia sickle cell disease.

Rosenberg A, Selounski V, Wardak H, Han J, Gowhari M, Hassan J, Jain S, Molokie RE, Gordeuk VR, Saraf SL.

Am J Hematol. 2016 Jun;91(6):E316-7. doi: 10.1002/ajh.24363. Epub 2016 Apr 24. No abstract available.

20.

Platelets decline during Vaso-occlusive crisis as a predictor of acute chest syndrome in sickle cell disease.

Alhandalous CH, Han J, Hsu L, Gowhari M, Hassan J, Molokie R, Abbasi TA, Gordeuk VR.

Am J Hematol. 2015 Dec;90(12):E228-9. doi: 10.1002/ajh.24214. Epub 2015 Nov 17. No abstract available.

21.

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.

Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, Campbell-Lee S, Gowhari M, Hassan J, Peace D, Quigley JG, Khan I, Molokie RE, Hsu LL, Mahmud N, Levinson DJ, Pickard AS, Garcia JG, Gordeuk VR, Rondelli D.

Biol Blood Marrow Transplant. 2016 Mar;22(3):441-8. doi: 10.1016/j.bbmt.2015.08.036. Epub 2015 Sep 5.

22.

Genetic polymorphism of APOB is associated with diabetes mellitus in sickle cell disease.

Zhang X, Zhang W, Saraf SL, Nouraie M, Han J, Gowhari M, Hassan J, Miasnikova G, Sergueeva A, Nekhai S, Kittles R, Machado RF, Garcia JG, Gladwin MT, Steinberg MH, Sebastiani P, McClain DA, Gordeuk VR.

Hum Genet. 2015 Aug;134(8):895-904. doi: 10.1007/s00439-015-1572-3. Epub 2015 May 30.

23.

Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, Lai C, Rowe JH, Gowhari M, Hassan J, Desimone J, Machado RF, Gladwin MT, Little JA, Gordeuk VR.

Br J Haematol. 2014 Mar;164(5):729-39. doi: 10.1111/bjh.12690. Epub 2013 Dec 12.

24.

Standard clinical practice underestimates the role and significance of erythropoietin deficiency in sickle cell disease.

Saraf S, Farooqui M, Infusino G, Oza B, Sidhwani S, Gowhari M, Vara S, Gao W, Krauz L, Lavelle D, DeSimone J, Molokie R, Saunthararajah Y.

Br J Haematol. 2011 May;153(3):386-92. doi: 10.1111/j.1365-2141.2010.08479.x. Epub 2011 Mar 21.

PMID:
21418176
25.

Prevalence of Cryptosporidium infection in camels (Camelus dromedarius) in a slaughterhouse in Iran.

Razawi SM, Oryan A, Bahrami S, Mohammadalipour A, Gowhari M.

Trop Biomed. 2009 Dec;26(3):267-73.

26.

Clinical effectiveness of decitabine in severe sickle cell disease.

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Br J Haematol. 2008 Apr;141(1):126-9. doi: 10.1111/j.1365-2141.2008.07027.x. No abstract available.

PMID:
18324975
27.

Supplemental Content

Loading ...
Support Center